REPORTS

Let’s Pullulate and Expand Your Business

Dendritic Cell Cancer Vaccine Market - Global Professional Analysis and Forecast to 2026

Jan 13, 2020  |  188 PAGES  |  REPORT CODE: CMM261223
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Dendritic Cell Cancer Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.2% during the forecast period.

This report presents the market size and development trends by detailing the Dendritic Cell Cancer Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Dendritic Cell Cancer Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Dendritic Cell Cancer Vaccine industry and will help you to build a panoramic view of the industrial development.

Dendritic Cell Cancer Vaccine Market, By Type:

  • CreaVax

  • Sipuleucel-T (Provenge)

  • Others

Dendritic Cell Cancer Vaccine Market, By Application:

  • Others

  • Others

  • Others

Some of the leading players are as follows:

  • Medigene

  • Glaxo Smith Kline

  • Vaxil Bio

  • Activarti

  • Merck

  • Bellicum Pharmaceuticals

  • Medigene

  • Creagene

  • Argos Therapeutics

  • Kiromic

  • Tella

  • DanDrit Biotech

  • Immunicum

  • Batavia Bioservices

  • ImmunoCellular

  • Northwest Biotherapeutics

  • Elios Therapeutics

  • DCPrime

  • Sanpower Corporation (Dendreon)

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Dendritic Cell Cancer Vaccine Market: Technology Type Analysis

  • 4.1 Dendritic Cell Cancer Vaccine Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Dendritic Cell Cancer Vaccine Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 CreaVax

    • 4.3.2 Sipuleucel-T (Provenge)

    • 4.3.3 Others

5 Dendritic Cell Cancer Vaccine Market: Product Analysis

  • 5.1 Dendritic Cell Cancer Vaccine Product Market Share Analysis, 2018 & 2026

  • 5.2 Dendritic Cell Cancer Vaccine Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Dendritic Cell Cancer Vaccine Market: Application Analysis

  • 6.1 Dendritic Cell Cancer Vaccine Application Market Share Analysis, 2018 & 2026

  • 6.2 Dendritic Cell Cancer Vaccine Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Others

    • 6.3.2 Others

    • 6.3.3 Others

7 Dendritic Cell Cancer Vaccine Market: Regional Analysis

  • 7.1 Dendritic Cell Cancer Vaccine Regional Market Share Analysis, 2018 & 2026

  • 7.2 Dendritic Cell Cancer Vaccine Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Medigene

    • 9.1.1 Medigene Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Glaxo Smith Kline

    • 9.2.1 Glaxo Smith Kline Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Vaxil Bio

    • 9.3.1 Vaxil Bio Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Activarti

    • 9.4.1 Activarti Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Merck

    • 9.5.1 Merck Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Bellicum Pharmaceuticals

    • 9.6.1 Bellicum Pharmaceuticals Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Medigene

    • 9.7.1 Medigene Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Creagene

    • 9.8.1 Creagene Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Argos Therapeutics

    • 9.9.1 Argos Therapeutics Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Kiromic

    • 9.10.1 Kiromic Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Tella

    • 9.11.1 Tella Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 DanDrit Biotech

    • 9.12.1 DanDrit Biotech Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Immunicum

    • 9.13.1 Immunicum Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Batavia Bioservices

    • 9.14.1 Batavia Bioservices Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 ImmunoCellular

    • 9.15.1 ImmunoCellular Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Northwest Biotherapeutics

    • 9.16.1 Northwest Biotherapeutics Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Elios Therapeutics

    • 9.17.1 Elios Therapeutics Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 DCPrime

    • 9.18.1 DCPrime Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Sanpower Corporation (Dendreon)

    • 9.19.1 Sanpower Corporation (Dendreon) Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

 

The List of Tables and Figures (Totals 72 Figures and 146 Tables)

  • Figure CreaVax Dendritic Cell Cancer Vaccine market, 2015 - 2026 (USD Million)

  • Figure Sipuleucel-T (Provenge) Dendritic Cell Cancer Vaccine market, 2015 - 2026 (USD Million)

  • Figure Others Dendritic Cell Cancer Vaccine market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Dendritic Cell Cancer Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table North America Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table North America Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table North America Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Canada Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Canada Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Europe Dendritic Cell Cancer Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Europe Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Europe Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Europe Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Germany Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Germany Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table France Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table France Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Italy Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Italy Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Spain Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Spain Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Dendritic Cell Cancer Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table China Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table China Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Japan Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Japan Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table India Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table India Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Dendritic Cell Cancer Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table MEA Dendritic Cell Cancer Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table MEA Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table MEA Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table MEA Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Dendritic Cell Cancer Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Dendritic Cell Cancer Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Dendritic Cell Cancer Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Medigene Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Glaxo Smith Kline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Vaxil Bio Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Activarti Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bellicum Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Medigene Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Creagene Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Argos Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Kiromic Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Tella Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table DanDrit Biotech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Immunicum Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Batavia Bioservices Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ImmunoCellular Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Northwest Biotherapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Elios Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table DCPrime Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanpower Corporation (Dendreon) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top